Turning Point Therapeutics granted breakthrough therapy designation for Repotrectinib treatment

Clinical Impact

Oct 4

Written By Frances Benson

https://www.tptherapeutics.com/news-releases/news-release-details/turning-point-therapeutics-granted-breakthrough-therapy

2021

Frances Benson

Bicycle Therapeutics announces preliminary results from Ph1 oncology trials

MiroBio appoints Dr. Carolin Barth as CEO